Substituted acyclic sulfonamides as human cannabinoid-1 receptor inverse agonists (original) (raw)
Synthesis and evaluation of N-[(1S,2S)-3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-methyl-2-aminopropanamide as human cannabinoid-1 receptor (CB1R) inverse agonists
Julie Lao, Chun-Pyn Shen
Bioorganic & Medicinal Chemistry Letters, 2009
View PDFchevron_right
Pyridopyrimidine based cannabinoid-1 receptor inverse agonists: Synthesis and biological evaluation
Julie Lao, Alison Strack, Chun-Pyn Shen
Bioorganic & Medicinal Chemistry Letters, 2009
View PDFchevron_right
Optimization of triaryl bis-sulfones as cannabinoid-2 receptor ligands
Neng-Yang Shih
Bioorganic & Medicinal Chemistry Letters, 2007
View PDFchevron_right
New bicyclic cannabinoid receptor-1 (CB1-R) antagonists
Denise Gautreau, John Hadcock
Bioorganic & Medicinal Chemistry Letters, 2006
View PDFchevron_right
Novel sulfenamides and sulfonamides based on pyridazinone and pyridazine scaffolds as CB 1 receptor ligand antagonists
Gabriele Murineddu
Bioorganic & Medicinal Chemistry, 2018
View PDFchevron_right
Synthesis and Characterization of NESS 0327: A Novel Putative Antagonist of the CB1 Cannabinoid Receptor
Gérard Pinna
Journal of Pharmacology and Experimental Therapeutics, 2003
View PDFchevron_right
Chemical Synthesis, Pharmacokinetic Properties and Biological Effects of JM-00266, a Putative Non-Brain Penetrant Cannabinoid Receptor 1 Inverse Agonist
christine belloir
International Journal of Molecular Sciences, 2022
View PDFchevron_right
Discovery of potent and orally bioavailable heterocycle-based cannabinoid CB1 receptor agonists
John Hadcock
Bioorganic & Medicinal Chemistry Letters, 2011
View PDFchevron_right
CB2 selective sulfamoyl benzamides: Optimization of the amide functionality
Bertrand Le Bourdonnec
Bioorganic & Medicinal …, 2009
View PDFchevron_right
1-Benzhydryl-3-phenylurea and 1-Benzhydryl-3-phenylthiourea Derivatives: New Templates among the CB 1 Cannabinoid Receptor Inverse Agonists
Jacques Poupaert
Journal of Medicinal Chemistry, 2005
View PDFchevron_right
Bioisosteric replacement of the hydrazide pharmacophore of the cannabinoid-1 receptor antagonist SR141716A. Part I: Potent, orally-active 1,4-disubstituted imidazoles
John Hadcock
Bioorganic & Medicinal Chemistry Letters, 2009
View PDFchevron_right
Evaluation of carboxamide-type synthetic cannabinoids as CB1/CB2 receptor agonists: difference between the enantiomers
Toshinari Suzuki
Forensic Toxicology, 2017
View PDFchevron_right
N-acyl-dopamines: novel synthetic CB1 cannabinoid-receptor ligands and inhibitors of anandamide inactivation with cannabimimetic activity in vitro and in vivo
Vladimir Bezuglov, Dominique Melck, Luciano De Petrocellis, Luciano Petrocellis
Biochemical Journal, 2000
View PDFchevron_right
Arachidonylsulfonyl derivatives as cannabinoid CB1 receptor and fatty acid amide hydrolase inhibitors
Yoffi Segall
Bioorganic & Medicinal Chemistry Letters, 2003
View PDFchevron_right
Design and synthesis of the CB1 selective cannabinoid antagonist AM281: A potential human SPECT ligand
Ruoxi Lan
AAPS PharmSci, 1999
View PDFchevron_right
Design, synthesis, and pharmacological characterization of indol-3-ylacetamides, indol-3-yloxoacetamides, and indol-3-ylcarboxamides: potent and selective CB2 cannabinoid receptor inverse agonists
Serena Pasquini, Simone Brogi
Journal of medicinal chemistry, 2012
View PDFchevron_right
Discovery of 7-Oxopyrazolo[1,5- a ]pyrimidine-6-carboxamides as Potent and Selective CB 2 Cannabinoid Receptor Inverse Agonists
Cristina Tintori
Journal of Medicinal Chemistry, 2013
View PDFchevron_right
A Pyridone Analogue of Traditional Cannabinoids. A New Class of Selective Ligands for the CB2 Receptor
John Huffman
Bioorganic & Medicinal Chemistry, 2001
View PDFchevron_right
New Pyridone-Based Derivatives as Cannabinoid Receptor Type 2 Agonists
HERY CHUNG
International Journal of Molecular Sciences, 2021
View PDFchevron_right
Diaryl Piperidines As CB1 Receptor Antagonists
Yan Xia
Bioorganic & medicinal …, 2010
View PDFchevron_right
New pyridazinone-4-carboxamides as new cannabinoid receptor type-2 inverse agonists: Synthesis, pharmacological data and molecular docking
Gabriele Murineddu
European journal of medicinal chemistry, 2017
View PDFchevron_right
Discovery of N-(3-(morpholinomethyl)-phenyl)-amides as potent and selective CB2 agonists
Damian Weaver
Bioorganic & Medicinal Chemistry Letters, 2009
View PDFchevron_right
The therapeutic applications of cannabinoid agonists and antagonists
François Petitet
Emerging Drugs, 1998
View PDFchevron_right
Triaryl bis-sulfones as cannabinoid-2 receptor ligands: SAR studies
Neng-Yang Shih
Bioorganic & Medicinal Chemistry Letters, 2005
View PDFchevron_right